
Pharmacally
Disease & Drugs
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Disease & Drugs
ResearchAn Update on mRNA Cancer Vaccines: A New Frontier in OncologyWritten and Reviewed by Team Pharmacally With promising results from early-phase clinical trials and ongoing developments, mRNA cancer vaccines are…Fact-Checked
ResearchThe Mitochondrial Heist: How Cancer Cells Hijack Immune Cells to Evade DestructionWritten and Reviewed by Team Pharmacally Recent research from the Chiba Cancer Center Research Institute in Chiba, Japan, published in…Fact-Checked
ResearchBrECADD: A Modern Approach to Advanced-Stage Classical Hodgkin Lymphoma TreatmentWritten and Reviewed by Team Pharmacally Classically, Hodgkin lymphoma (cHL) is highly treatable, yet its treatment for advanced stages is…Fact-Checked
ResearchDesigned by Intelligence: AI-Engineered Proteins Revolutionize Antivenom ScienceWritten and Reviewed by Team Pharmacally Researchers led by Timothy Patrick Jenkins, PhD, from the Technical University of Denmark, and…Fact-Checked
New Drug ApprovalJazz Pharmaceuticals reports that Ziihera® (zanidatamab-hrii) has received FDA for the treatment of adults with HER2-positive (IHC 3+) biliary tract cancer (BTC) that has been previously treated and is either incurable or metastaticWritten and Reviewed by Team Pharmacally The U.S. Food and Drug Administration (FDA) gave Ziihera® (zanidatamab-hrii) expedited approval on November…Fact-Checked
New Drug ApprovalZepbound Cleared by FDA for Moderate to Severe Sleep Apnea in Obese PopulationsWritten and Reviewed by Team Pharmacally Zepbound (tirzepatide), the first drug approved by the U.S. Food and Drug Administration (FDA)…Fact-Checked
New Drug ApprovalA First-in-Class Sodium Channel Blocker for Acute Pain: FDA Approves Vertex’s JOURNAVX™ (suzetrigine) after 25 years of last approved pain killer Written and Reviewed by Team Pharmacally The US Food and Drug Administration (FDA) have sanctioned Vertex Pharmaceuticals JOURNAVXTM (suzetrigine), a…Fact-Checked
ResearchArtificial Intelligence in Medicine: Revolutionizing HealthcareWritten and Reviewed by Team Pharmacally Healthcare is one of the many areas that artificial intelligence (AI) is quickly changing.Fact-Checked
ResearchSeven-Minute Cancer Treatment Shot: Revolutionizing Oncology with AtezolizumabWritten and Reviewed by Team Pharmacally In a groundbreaking development, the introduction of a seven-minute cancer treatment shot using the…Fact-Checked
New Drug ApprovalFDA Approval of Ryoncil (Remestemcel-L): A New Frontier in Regenerative MedicineWritten and Reviewed by Team Pharmacally Mesoblast Limited’s mesenchymal stem cell therapy, Ryoncil (Remestemcel-L), was recently approved by the U.S.Fact-Checked
New Drug ApprovalFDA Approves Penmenvy, the First Pentavalent Vaccine for Comprehensive Invasive Meningococcal Disease PreventionWritten and Reviewed by Team Pharmacally Breakthrough Immunization Covers Five Major Serogroups, Simplifying Protection against Deadly Infections The U.S. Food…Fact-Checked
New Drug ApprovalFirst Non-prescription Daily Oral Contraceptive: OpillWritten and Reviewed by Team Pharmacally The U.S. Food and Drug Administration (FDA) approved Opill, the first daily oral contraceptive…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.